Actively Recruiting
Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases
Led by Qilu Hospital of Shandong University · Updated on 2025-09-09
214
Participants Needed
1
Research Sites
94 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center randomized controlled trial. Eligible subjects meeting inclusion/exclusion criteria will be randomized 1:1 to EUS+ERCP group or ERCP group. Clinical data and patient-reported outcomes are regularly collected at baseline and during follow-up periods. A comparative analysis was conducted to assess the impact of same-session EUS on ERCP strategy modification between two groups, utilizing a structured questionnaire.Secondarily, the safety and efficacy of same-session EUS will be comprehensively evaluated by comparing complication rates, technical success rate and hospitalization costs, length of stay, and radiation exposure between groups.
CONDITIONS
Official Title
Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years
- Patients with pancreaticobiliary diseases definitively indicated for ERCP as confirmed by hepatobiliary-pancreatic specialists
- No prior history of ERCP
- No pancreaticobiliary EUS examinations within the preceding 3 months
You will not qualify if you...
- Patients with malignant lesions deemed surgically unresectable requiring pathology only for chemotherapy/radiotherapy guidance
- Patients requiring only palliative biliary or pancreatic stent placement for obstructive jaundice
- Patients with anatomical changes or surgical history preventing EUS feasibility
- Severe systemic illnesses including serious liver, kidney, heart, lung, or brain diseases that increase risk for endoscopy
- Contraindications to iodinated contrast media such as allergy or renal impairment
- Pregnancy or breastfeeding
- Severe bleeding disorders
- Declined informed consent
- Severe psychiatric disorders or inability to cooperate making safe procedure impossible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250000
Actively Recruiting
Research Team
Z
Zhen Li, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here